Dividend Consideration: Elite Diagnostic Limited (ELITE)

July 26, 2021

Elite Diagnostic Limited (ELITE)  has advised that further to the Company’s previous announcements regarding an interim dividend payable on August 5, 2021, the Company will not be able to meet this timeframe. ELITE has further advised that the internal processes needed to handle this exercise are not expected to be completed in time. In light of this, the Board of ELITE has agreed to adjust the payment date from August 5, 2021 to October 5, 2021. The dividend will be payable to shareholders on record as at August 5, 202


Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.